VIR Operating Cash Flow (Statement)
Vir Biotechnology Inc · Operating Cash Flow (Statement)
VIR Operating Cash Flow (Statement)
Latest reported-$202.51Mperiod ending
VIR TTM Cash from Operations (-$94.10M → -$202.51M)
TTM operating cash flow (statement)
High-resolution chart · PNG
VIR operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -202,506,000 | |
| -446,051,000 | |
| -391,781,000 | |
| -453,540,000 | |
| -457,450,000 | |
| -415,078,000 | |
| -446,352,000 | |
| -466,644,000 | |
| -450,993,000 | |
| -762,393,000 | |
| -778,785,000 | |
| -635,732,000 | |
| -362,001,000 | |
| 987,382,000 | |
| 1,663,253,000 | |
| 1,635,821,999 | |
| 1,412,106,999 | |
| 592,028,999 | |
| -47,589,001 | |
| -137,336,000 | |
| -81,364,000 | |
| -232,061,000 | |
| -190,941,000 | |
| -147,774,000 | |
| -134,888,000 | |
| -148,552,000 | |
| -129,632,000 | |
| -120,255,000 | |
| -117,904,000 | |
| -108,593,000 | |
| -94,096,000 |